[1] THEYAB A, ALGAHTANI M, ALSHARIF K F, et al. New insight into the mechanism of granulocyte colony-stimulating factor(G-CSF)that induces the mobilization of neutrophils[J]. Hematology, 2021, 26(1): 628-636. doi:  10.1080/16078454.2021.1965725
[2] ABBOUD C N, LANG N, FUNG H, et al. Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo-filgrastim, short-acting recombinant human granulocyte colony-stimulating factors[J]. Support Care Cancer, 2019, 27(7): 2569-2577.
[3] 卢祥云, 马柯, 温大蔚, 等. 弥漫性肺泡出血病人死亡危险因素分析[J]. 青岛大学学报(医 学 版), 2021, 57(5): 721-724.
[4]

BAUMGARTNER M, ASHTON R. Diffuse alveolar hemorrhage[J]. South Med J, 2011, 104(4): 274-275. doi:  10.1097/SMJ.0b013e3182126d6d
[5] 向必晓, 左笑丛, 谢悦良. 粒细胞或粒细胞-巨噬细胞集落刺激因子致肺毒性临床特征分析[J]. 中南药学, 2023, 21(6): 1659-1663.
[6] 刘建影, 宫国华, 刘景娇. 1例健康供者应用重组人粒细胞集落刺激因子所致的弥漫性肺泡出血[J]. 临床肺科杂志, 2023, 28(11): 1780-1782.
[7] 杨华, 魏晶, 王嘉仡, 等. 药品不良反应/事件报告评价方法研究[J]. 中国药物警戒, 2009, 6(10): 581-584.
[8] 陈静静, 钱佩佩, 曹凯, 等. 我国药品不良反应关联性评价方法与诺氏评估量表法的对比与分析[J]. 中国药事, 2020, 34(8): 988-992.
[9] 倪磊, 李庆云. 应重视弥漫性肺泡出血综合征的诊治策略[J]. 内科理论与实践, 2016, 11(4): 202-204.
[10]

LARA A R, SCHWARZ M I. Diffuse alveolar hemorrhage[J]. Chest, 2010, 137(5): 1164-1171. doi:  10.1378/chest.08-2084
[11]

KANAOKA K, IKEBE S, IHARA S, et al. Durvalumab-induced diffuse alveolar hemorrhage: an autopsy case report[J]. Case Rep Oncol, 2020, 13(2): 696-701. doi:  10.1159/000507848
[12]

SAEKI S, NISHIMATSU K, IHARA S, et al. Osimertinib-induced unilateral diffuse alveolar hemorrhage in a patient with pulmonary adenocarcinoma[J]. J Med Cases, 2021, 12(7): 295-299. doi:  10.14740/jmc3702
[13]

DULL S K, JAGAN N, MOORE D R, et al. Diffuse alveolar hemorrhage following pirfenidone initiation[J]. J Pharm Pract, 2020, 33(4): 548-552. doi:  10.1177/0897190019841731
[14]

KOLBEN Y, DARAWSHY F, BARHOUM B, et al. Diffuse alveolar hemorrhage in a healthy stem cell donor following administration of granulocyte colony–stimulating factor[J]. Int Immunopharmacol, 2021, 99: 108019. doi:  10.1016/j.intimp.2021.108019
[15] 辛庆红, 张文博, 李继成, 等. 17 例弥漫性肺泡出血临床分析[J]. 中国呼吸与危重监护杂志, 2010, 9(6): 624-626.
[16] 郝兴亮, 纪艳荣, 张建, 等. 药物性弥漫性肺泡出血一例[J]. 中国呼吸与危重监护杂志, 2022, 21(12): 890-892.
[17]

SAEED MM, WOO MS, MAC L, et al. Prognosis in pediatric idiopathic pulmonary hemosiderosis[J]. Chest, 1999, 116(3): 721-725. doi:  10.1378/chest.116.3.721
[18]

UCHIYAMA M, IKEDA T. Diffuse alveolar hemorrhage after unrelated cord blood transplantation[J]. Bone Marrow Transplant, 2010, 45(4): 789-790. doi:  10.1038/bmt.2009.219
[19]

YATES M, WATTS RA, BAJEMA IM, et al. EULAR/ER-EDTA recommendations for the management of ANCA-associated vasculitis[J]. Ann Rheum Dis, 2016, 75(9): 1583-1594. doi:  10.1136/annrheumdis-2016-209133
[20] 徐作军. 应加强对药物性肺损伤的重视和认识[J]. 中华结核和呼吸杂志, 2017, 40(10): 721-723.
[21] 范梦瑶, 宋琳, 田泾. 临床药师参与 1 例肝衰竭患者糖皮质激素治疗的分析与药学监护[J]. 药学实践杂志, 2018, 36(5): 464-467.